Search Results - "Koury, Luisa C."
-
1
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia
Published in Blood (19-09-2019)“…By combining the analysis of mutations with aberrant expression of genes previously related to poorer prognosis in both acute promyelocytic leukemia (APL) and…”
Get full text
Journal Article -
2
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia
Published in British journal of haematology (01-01-2023)“…Summary Although a growing body of evidence demonstrates that altered mtDNA content (mtDNAc) has clinical implications in several types of solid tumours, its…”
Get full text
Journal Article -
3
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells
Published in Investigational new drugs (01-04-2022)“…Summary Stathmin 1 (STMN1) is a microtubule-destabilizing protein highly expressed in hematological malignancies and involved in proliferation and…”
Get full text
Journal Article -
4
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia
Published in Scientific reports (25-06-2020)“…Non-T cell activation linker (NTAL) is a lipid raft-membrane protein expressed by normal and leukemic cells and involved in cell signaling. In acute…”
Get full text
Journal Article -
5
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia
Published in Cancers (01-11-2020)“…The SLIT-ROBO axis plays an important role in normal stem-cell biology, with possible repercussions on cancer stem cell emergence. Although the Promyelocytic…”
Get full text
Journal Article -
6
Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia
Published in Blood advances (26-09-2017)“…Although overexpression of the brain and acute leukemia, cytoplasmic (BAALC) gene is associated with primary resistant disease and shorter relapse-free,…”
Get full text
Journal Article -
7
Clinical Significance of Mitochondrial DNA Content in Acute Promyelocytic Leukemia
Published in Blood (23-11-2021)“…Used in the clinical practice for more than three decades, the all-trans retinoic acid (ATRA) rendered acute promyelocytic leukemia (APL) the most curable…”
Get full text
Journal Article -
8
Arsenic Trioxide Abrogate MN1 Mediated RA-Resistance in Acute Promyelocytic Leukemia
Published in Blood (13-11-2019)“…Introduction: Described as a well know marker of worse prognosis in acute myeloid leukemia (AML), MN1 overexpression has been associated with inv(16) or EVI1…”
Get full text
Journal Article -
9
Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia
Published in Blood (13-11-2019)“…Background: TP73 isoforms gained particular relevance in acute promyelocytic leukemia (APL) since Bernasola et al (JEM. 2004) demonstrated that TAp73 was…”
Get full text
Journal Article -
10
Slit-Robo Pathway Is Clinically Relevant and May Represent a Potential Target in Acute Promyelocytic Leukemia
Published in Blood (29-11-2018)“…Background: The Slit-Robo pathway has been shown to participate in the pathogenesis of several malignant diseases in addition to its physiologic role during…”
Get full text
Journal Article -
11
Abstract A39: Nuclear SET domain (NSD) protein lysine methyltransferases (KMT) are higher expressed in acute myeloid leukemia
Published in Clinical cancer research (01-01-2018)“…Abstract The nuclear SET domain (NSD) protein lysine methyltransferases (KMT) family is composed of three members, NSD1/KMT3B, NSD2/WHSC1/MMSET, and…”
Get full text
Journal Article -
12
Combining Gene Mutation with Gene Expression Data Improves Outcomes Prediction in Acute Promyelocytic Leukemia
Published in Blood (08-12-2017)“…In the context of all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy, heterogeneity of clinical outcomes of patients with acute promyelocytic…”
Get full text
Journal Article -
13
Metformintreatment Overcomes ATRA-Resistance in Acute Promyelocytic Leukemia and Increases FOXO3A Expression
Published in Blood (29-11-2018)“…Introduction:FOXO3A is a transcription factor shown to be involved in all-trans retinoic acid (ATRA)-induced granulocytic differentiation and apoptosis in…”
Get full text
Journal Article -
14
Association between Nuclear SET Domain (NSD) Protein Lysine Methyltransferases (KMT) Expression and Poor Prognosis in Acute Promyelocytic Leukemia (APL) Patients Treated with ATRA and Anthracycline Protocol
Published in Blood (08-12-2017)“…Introduction: In the last decades, it has been described the potential role of Nuclear SET domain (NSD) Protein Lysine Methyltransferases (KMT) family members…”
Get full text
Journal Article -
15
The Use of Cyclosporine in Association with Chemotherapy As Induction Treatment in Patients with Acute Myeloid Leukemia (AML) and High Rhodamine Efflux at Diagnosis Results in Higher Complete Hematological Remission Rates, but Does Not Prolong Overall Survival
Published in Blood (03-12-2015)“…The overexpression of P-glycoprotein (Pgp) in leukemic blasts of Acute Myeloid Leukemia (AML) is associated with lower complete remission (CR) rates and…”
Get full text
Journal Article -
16
Nuclear SET Domain (NSD) Protein Lysine Methyltransferases (KMT) Family Members Expression in Acute Myeloid Leukemia
Published in Blood (02-12-2016)“…The Nuclear SET Domain (NSD) Protein Lysine Methyltransferases (KMT) family is composed of three members: NSD1/KMT3B, NSD2/WHSC1/MMSET and NSD3/WHSC1L1 which…”
Get full text
Journal Article